Stay updated on Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A sitewide NIH notice about the terminology transition appears above the unchanged 403 error page, and the footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:14:20.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T01:12:32.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details with a generic error message. This indicates an access or server problem affecting the visibility of the study record.
    Difference
    18%
    Check dated 2026-09-23T01:21:47.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.6 to v3.7.0 on the study page, indicating a backend/content update. The update does not modify the study data, eligibility criteria, outcomes, or locations.
    Difference
    0.1%
    Check dated 2026-09-16T00:46:44.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page’s revision label changed from v3.6.5 to v3.6.6, representing a minor update to the page’s documentation/version. No substantive content changes to the study details are indicated.
    Difference
    0.1%
    Check dated 2026-09-01T21:44:48.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added a funding source entry: 2017 ( U.S. NIH Grant/Contract ). This indicates NIH funding associated with the study.
    Difference
    0.1%
    Check dated 2026-08-25T21:57:47.000Z thumbnail image

Stay in the know with updates to Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.